Skip to content

Serum/plasma protein electrophoresis (qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test measures the different types of proteins in your blood using electrophoresis, a method that separates proteins based on size and charge.

Quick summary

["Helps identify abnormal protein patterns that may signal conditions like multiple myeloma, liver disease, or other disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
72562-2
Short code
CK MM CFr.DF SerPl Elph
Synonyms
CK MM CFr.DF SerPl Elph
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
22
Ref high
198
Critical range
7.2 N/A – 7.6 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
electrophoresis
CPT
82553
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

Electrophoresis separates blood proteins into five main zones: albumin, alpha-1 globulins, alpha-2 globulins, beta globulins, and gamma globulins. Each zone contains different proteins that help your body function, including antibodies, enzymes, and transport proteins. Abnormal patterns may indicate conditions like inflammation, infections, or genetic disorders.

Why It’s Ordered

Your healthcare provider may order this test if you have symptoms like unexplained weight loss, fatigue, swelling, or if tests suggest an issue with protein production or breakdown. It’s also used to monitor conditions like multiple myeloma, liver disease, or kidney problems.

Sample Collection

A blood sample is drawn from a vein, usually in your arm. You may feel a small pinch, but it shouldn’t cause significant discomfort. The blood is then sent to a lab for processing and analysis.

Preparation

No special preparation is needed, but avoid eating or drinking anything (except water) for 2–4 hours before the test if instructed. Inform your provider about any medications or supplements you’re taking.

Reference range

Adult males: 22-198 U/L; Females: 22-198 U/LN/A

Specimen: serum

No special preparation required. Inform provider of any chest pain or symptoms.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Frequently asked questions

Abnormal results may reveal conditions such as multiple myeloma (overproduction of abnormal proteins), liver disease (reduced albumin), or immune disorders (elevated gamma globulins). Low albumin could signal malnutrition or kidney issues.
This test doesn’t provide specific numbers for each protein zone, but patterns are compared to a baseline or known reference ranges to identify potential problems.
How long will results take?
Results are typically available within 2–3 business days, depending on lab processing times. Follow up with your provider to discuss findings.
What if my results are abnormal?
If results are abnormal, your provider may recommend further testing, such as additional protein analysis or imaging, to determine the cause. They’ll work with you to develop a treatment plan if needed.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy